These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10501907)
1. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Wang LG; Liu XM; Kreis W; Budman DR Cancer Chemother Pharmacol; 1999; 44(5):355-61. PubMed ID: 10501907 [TBL] [Abstract][Full Text] [Related]
2. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Srivastava RK; Srivastava AR; Korsmeyer SJ; Nesterova M; Cho-Chung YS; Longo DL Mol Cell Biol; 1998 Jun; 18(6):3509-17. PubMed ID: 9584191 [TBL] [Abstract][Full Text] [Related]
3. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Fan M; Du L; Stone AA; Gilbert KM; Chambers TC Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805 [TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways of taxanes-induced apoptosis. Ganansia-Leymarie V; Bischoff P; Bergerat JP; Holl V Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):291-306. PubMed ID: 12769774 [TBL] [Abstract][Full Text] [Related]
5. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608 [TBL] [Abstract][Full Text] [Related]
6. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells. Liu XM; Wang LG; Kreis W; Budman DR; Adams LM Br J Cancer; 2001 Nov; 85(9):1403-11. PubMed ID: 11720482 [TBL] [Abstract][Full Text] [Related]
8. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Stone AA; Chambers TC Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471 [TBL] [Abstract][Full Text] [Related]
9. Implication of bax in apoptosis depends on microtubule network mobility. Longuet M; Serduc R; Riva C Int J Oncol; 2004 Aug; 25(2):309-17. PubMed ID: 15254727 [TBL] [Abstract][Full Text] [Related]
10. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Zelivianski S; Spellman M; Kellerman M; Kakitelashvilli V; Zhou XW; Lugo E; Lee MS; Taylor R; Davis TL; Hauke R; Lin MF Int J Cancer; 2003 Nov; 107(3):478-85. PubMed ID: 14506750 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells. Kim R; Ohi Y; Inoue H; Toge T Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693 [TBL] [Abstract][Full Text] [Related]
12. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Masuda A; Maeno K; Nakagawa T; Saito H; Takahashi T Am J Pathol; 2003 Sep; 163(3):1109-16. PubMed ID: 12937152 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Mhaidat NM; Zhang XD; Jiang CC; Hersey P Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842 [TBL] [Abstract][Full Text] [Related]
14. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077 [TBL] [Abstract][Full Text] [Related]
15. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. Pathan N; Aime-Sempe C; Kitada S; Haldar S; Reed JC Neoplasia; 2001; 3(1):70-9. PubMed ID: 11326318 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors. Skobeleva N; Menon S; Weber L; Golemis EA; Khazak V Mol Cancer Ther; 2007 Mar; 6(3):898-906. PubMed ID: 17363484 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194 [TBL] [Abstract][Full Text] [Related]
18. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663 [TBL] [Abstract][Full Text] [Related]
19. Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines. Serafin AM; Bohm L Urol Oncol; 2005; 23(2):123-9. PubMed ID: 15869997 [TBL] [Abstract][Full Text] [Related]
20. Bcl2 is the guardian of microtubule integrity. Haldar S; Basu A; Croce CM Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]